Adia Nutrition, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
Adia Med, Inc. has fully repaid and discharged its $1,000,000 unsecured revolving line of credit provided by its CEO, Larry Powalisz.
OQB
Adia Nutrition has initiated a legal action seeking to quiet title on over 29 million shares of its common stock, alleging they were improperly issued.
OQB
Adia Nutrition, Inc. has entered into an engagement letter with Lucosky Brookman LLP to provide legal counsel for its planned uplisting to the NASDAQ Capital Market and a contemplated bridge financing transaction.
OQB
Adia Nutrition, Inc. has officially changed its corporate name to Adia Med, Inc., with the change effective June 2, 2026, and FINRA approval received on July 10, 2026.